뒤로
Hoth Therapeutics Inc(HOTH) 가격
HOTH 주가 차트
HOTH 배당금
Hoth Therapeutics Inc
$1.04
-3.7%
$-0.04
종가: Jan 16, 16:00:00 GMT-5
$1.04
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$1.08
시가
$1.06
일일 범위
$1.03 - $1.09
52주 범위
$0.655 - $2.11
거래량
354.2K
평균 거래량
331.8K
EPS(TTM)
-1.64
배당수익률
--
시가총액
$16.1M
HOTH란 무엇인가요?
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2019-02-15. The firm is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The firm also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).